ANI Pharmaceuticals-Compared to Estimates, ANI (ANIP) Q4 Earnings: A Look at Key Metrics

For the quarter ended December 2023, ANI Pharmaceuticals (ANIP) reported revenue of $131.65 million, up 39.7% over the same period last year. EPS came in at$ 1.00, compared to $0.76 in the year-ago quarter.The reported revenue represents a surprise of +7.02% over the Zacks Consensus Estimate of$ 123.02 million. With the consensus EPS estimate being $0.80, the EPS surprise was +25.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to ...